FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1486-1487 May 20, 1993 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Although it is easy to dismiss problems such as postinflammatory hyperpigmentation under the rubric of "cosmetic concerns," pigmentary disorders are a frequent cause of distress because of our society's excessive focus on appearance. Postinflammatory hyperpigmentation is a common cause of visits to the dermatologist, and the number of agents available for its treatment is limited. The report by Bulengo-Ransby and colleagues on the efficacy of tretinoin (retinoic acid) as a single agent in black persons with postinflammatory skin hyperpigmentation in this issue of the Journal¹ adds to our knowledge about both tretinoin and the hyperpigmentation itself.

The use of tretinoin . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.